Advertisement
Screener

Cellcyte Genetics Corp. Cash and Cash Equivalents

Cellcyte Genetics Corp. Cash and Cash Equivalents

Cellcyte Genetics Corp. had Cash and Cash Equivalents of -$31.86 thousand as of 2013-06-30, per its 10-Q filed 2013-08-19.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2013-08-19

  • 2013-06-30: Cash and Cash Equivalents, at Carrying Value -$31.86K.
  • 2009-12-31: Cash and Cash Equivalents, at Carrying Value $7.30K.
Period endCash and Cash Equivalents, at Carrying Value
2013-06-30-$31.86K
10-Q · filed 2013-08-19
2009-12-31$7.30K
10-K · filed 2012-04-16